Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. provided earnings guidance for the year 2018. The company predicts a loss in its the net profit belonging to shareholders of the listed company in 2018, with the net profit belonging to shareholders of the company to be between negative RMB 130 million and negative RMB 110 million compared with the same period of the year before. The net profit belonging to shareholders of the company after excluding extraordinary profit and loss will be between negative RMB 160 million and negative RMB 140 million.